Rajesh Tampi, MD, professor and inaugural chair of the Bhatia Family Endowed Chair in Psychiatry, recently published an article, "New Medication, Staging Criteria Signal a Potential Shift in Alzheimer’s Care," in a journal by the American Psychiatric Association.
The latest antibody treatment for Alzheimer’s disease may prompt the industry toward the use of biomarkers—rather than traditional cognitive and functional testing—for diagnosis and staging. Will the new drug make a meaningful difference in patients’ lives despite its risks and hefty price tag?
Read more in the publication online.